Gain Therapeutics
GANX
GANX
21 hedge funds and large institutions have $3.74M invested in Gain Therapeutics in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 3 closing their positions.
Holders
21
Holders Change
-2
Holders Change %
-8.7%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
7
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BCM
1
Bridgeway Capital Management
Houston,
Texas
|
$188K |
2 |
TSS
2
Two Sigma Securities
New York
|
$39.9K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$22.8K |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$282K |
5 |
5
BlackRock
New York
|
$78.2K |